Technology area: Biotechnology & Pharmaceuticals
51 pending office actions • 38 art units • 51 examiners • 1 of 51 (2%) have an AI response strategy ready • 70 patents granted in the last 365 days
University of Southern California has 53 pending office actions in Biotechnology & Pharmaceuticals. Each action is associated with a distinct examiner, while the matters occupy 39 art units. The data therefore shows complete examiner dispersion alongside some technical-unit overlap.
REMALY, MARK DONALD is the busiest examiner, with 1 pending action. Portfolio counsel should use centralized deadline control and art-unit issue analysis, since no examiner carries more than that amount in the supplied docket.
Based on the USPTO statutory response window for each pending office action. 10 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 10 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 2 (4%) |
| §101 + other | 11 (22%) |
| §103 only | 11 (22%) |
| §102 only | 4 (8%) |
| §112 only | 3 (6%) |
| Double-patenting + other | 1 (2%) |
| Multi-statute (no §101) | 19 (37%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| REMALY, MARK DONALD | 1 | 70.5% | +15.9% |
| KO, TONY | 1 | 87.8% | +2.8% |
| MUSTAFA, IMRAN K | 1 | 60.4% | +15.9% |
| LEE, BRYAN MCALLISTER | 1 | 93.1% | +9.5% |
| GANGLE, BRIAN J | 1 | 76.8% | +14.6% |
| TRAN, ANH Q | 1 | 90.2% | +5.0% |
| FERNANDEZ, KATHERINE L | 1 | 58.0% | +37.8% |
| NAKHJAVAN, SHERVIN K | 1 | 88.0% | +11.4% |
| TEHRANI, DANIEL | 1 | 60.9% | +41.9% |
| LUONG, PETER | 1 | 69.4% | +26.2% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18887555 | PERSONALIZED PROFILING OF FUTURE BRAIN TRAJECTORIES AND FUTURE DISEASE EVOLUTION USING GENERATIVE ARTIFICIAL INTELLIGENCE | NAKHJAVAN, SHERVIN K | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18184497 | ORGANIC PHOTOSENSITIVE DEVICES WITH EXCITON-BLOCKING CHARGE CARRIER FILTERS | CHERN, CHRISTINA | 85d overdue |
| 18934954 | PHYSIOLOGICAL METRICS FOR DETERMINING STROKE RISK | FERNANDEZ, KATHERINE L | 36d overdue |
| 18273181 | Use Of Naturally Occurring Cyclic Peptides For Treatment Of SARS-COV-2 Infection | BOWLES, DAVID PAUL | 4d overdue |
| 18401817 | THIN FILM ENDOVASCULAR ELECTRODE ARRAY AND METHOD OF FABRICATION | PREMRAJ, CATHERINE C | 14d |
| 18554917 | PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES | ALAWADI, SARAH | 70d |
| 17794920 | COMPOSITIONS AND METHODS TO TREAT NEUROLOGICAL DISEASES | GIBBS, TERRA C | 72d |
| 19164913 | AIRWAY EXCHANGE BRONCHOSCOPE CONSTRUCTION | REMALY, MARK DONALD | — |
| 19079287 | COHERENT DETECTION FOR THE IDENTIFICATION OF SCATTERED LASER LIGHT IN A BRIGHT INCOHERENT BACKGROUND | KO, TONY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18934954 | PHYSIOLOGICAL METRICS FOR DETERMINING STROKE RISK | FERNANDEZ, KATHERINE L | 36d overdue |
| 19164913 | AIRWAY EXCHANGE BRONCHOSCOPE CONSTRUCTION | REMALY, MARK DONALD | — |
| 19106909 | COORDINATION OF VEHICLE OPERATION | MUSTAFA, IMRAN K | — |
| 18962908 | FASTING-MIMICKING DIET (FMD) BUT NOT WATER-ONLY FASTING PROMOTES REVERSAL OF INFLAMMATION AND IBD PATHOLOGY | GANGLE, BRIAN J | — |
| 18887555 | PERSONALIZED PROFILING OF FUTURE BRAIN TRAJECTORIES AND FUTURE DISEASE EVOLUTION USING GENERATIVE ARTIFICIAL INTELLIGENCE | NAKHJAVAN, SHERVIN K | — |
| 18818488 | TRANSCUTANEOUS ELECTRICAL SPINAL CORD NEUROMODULATOR AND USES THEREOF | TEHRANI, DANIEL | — |
| 18734823 | METHOD AND SYSTEM FOR OBSERVING BRAIN STATES WITH FUNCTIONAL ULTRASOUND IMAGING AND A SONOLUCENT INTERFACE | LUONG, PETER | — |
| Art Unit | Apps |
|---|---|
| 1658 | 4 |
| 1633 | 3 |
| 3797 | 2 |
| 1645 | 2 |
| 3798 | 2 |
| 3792 | 2 |
| 2127 | 2 |
| 1635 | 2 |
| 1682 | 2 |
| 2878 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19164913 | AIRWAY EXCHANGE BRONCHOSCOPE CONSTRUCTION | REMALY, MARK DONALD | 3797 | §102§103 | Non-Final OA | — | Pending | Sep 12, 2025 |
| 19079287 | COHERENT DETECTION FOR THE IDENTIFICATION OF SCATTERED LASER LIGHT IN A BRIGHT INCOHERENT BACKGROUND | KO, TONY | 2878 | §101§102§112 | Non-Final OA | — | Pending | Mar 13, 2025 |
| 19106909 | COORDINATION OF VEHICLE OPERATION | MUSTAFA, IMRAN K | 3668 | §101§103 | Non-Final OA | — | Pending | Feb 26, 2025 |
| 19052850 | ELECTRIC-FIELD DIRECTED NERVE REGENERATION | LEE, BRYAN MCALLISTER | 3796 | §101§103 | Non-Final OA | — | Pending | Feb 13, 2025 |
| 18962908 | FASTING-MIMICKING DIET (FMD) BUT NOT WATER-ONLY FASTING PROMOTES REVERSAL OF INFLAMMATION AND IBD PATHOLOGY | GANGLE, BRIAN J | 1645 | §102 | Non-Final OA | — | Pending | Nov 27, 2024 |
| 18866501 | High-Speed Compact Look-Up Table with Input Select and Registers | TRAN, ANH Q | 2844 | §102§103 | Non-Final OA | — | Pending | Nov 15, 2024 |
| 18934954 | PHYSIOLOGICAL METRICS FOR DETERMINING STROKE RISK | FERNANDEZ, KATHERINE L | 3798 | §103§112 | Final Rejection | 36d overdue | Pending | Nov 01, 2024 |
| 18887555 | PERSONALIZED PROFILING OF FUTURE BRAIN TRAJECTORIES AND FUTURE DISEASE EVOLUTION USING GENERATIVE ARTIFICIAL INTELLIGENCE | NAKHJAVAN, SHERVIN K | 2672 | §103 | Non-Final OA | — | Pending | Sep 17, 2024 |
| 18818488 | TRANSCUTANEOUS ELECTRICAL SPINAL CORD NEUROMODULATOR AND USES THEREOF | TEHRANI, DANIEL | 3792 | §103§112 | Non-Final OA | — | Pending | Aug 28, 2024 |
| 18734823 | METHOD AND SYSTEM FOR OBSERVING BRAIN STATES WITH FUNCTIONAL ULTRASOUND IMAGING AND A SONOLUCENT INTERFACE | LUONG, PETER | 3797 | §102§103 | Non-Final OA | — | Pending | Jun 05, 2024 |
| 18714060 | SCHEDULING DISTRIBUTED COMPUTING BASED ON COMPUTATIONAL AND NETWORK ARCHITECTURE | NGUYEN, AMANDA DANG | 2127 | §101§102§103§112 | Non-Final OA | — | Pending | May 28, 2024 |
| 18710880 | MULTIWAVELET-BASED OPERATOR LEARNING FOR DIFFERENTIAL EQUATIONS | SHELTON, SETH CAPRIANO-UMA | — | §101§103 | Non-Final OA | — | Pending | May 16, 2024 |
| 18703290 | DIRECT HYDROGENATION OF METAL CARBONATE AND RELATED SALTS TO METHANOL, METHANE AND METAL HYDROXIDE | WITHERSPOON, SIKARL A | 1692 | §102§103 | Non-Final OA | — | Pending | Apr 19, 2024 |
| 18702327 | COMPOSITE PREPREG CONSTRUCTIONS AND METHODS FOR MAKING THE SAME | DAGENAIS, KRISTEN A | 1781 | §103 | Non-Final OA | — | Pending | Apr 17, 2024 |
| 18625740 | HUMAN CEREBELLAR ORGANOIDS WITH BONA FIDE PURKINJE CELLS AND USES THEREOF | SMALL, KATHERINE R | 1633 | §112 | Non-Final OA | — | Pending | Apr 03, 2024 |
| 18682656 | SYSTEMS AND METHODS FOR IMPROVED SECURE AGGREGATION IN FEDERATED LEARNING | HOOVER, BRENT JOHNSTON | 2127 | §101§102§103§112 | Non-Final OA | — | Pending | Feb 09, 2024 |
| 18430372 | BACKSIDE OPTICAL COUPLER | MOONEY, MICHAEL P | 2874 | §102 | Non-Final OA | — | Pending | Feb 01, 2024 |
| 18580889 | GENETICALLY ENGINEERED MULTIFUNCTIONAL EXOSOMES FOR IMMUNOTHERAPY | NICKOL, GARY B | 1643 | §102§112DP | Non-Final OA | — | Pending | Jan 19, 2024 |
| 18401817 | THIN FILM ENDOVASCULAR ELECTRODE ARRAY AND METHOD OF FABRICATION | PREMRAJ, CATHERINE C | 3794 | §102§103 | Final Rejection | 14d | Pending | Jan 02, 2024 |
| 18402685 | SYSTEMS AND METHODS TO ACCELERATE GEL-SOL TRANSITION FOR THERMORESPONSIVE HYDROGELS | AZPURU, CARLOS A | 1617 | §102§103 | Non-Final OA | — | Pending | Jan 02, 2024 |
| 18573421 | MONOLITHIC PERICARDIAL PACEMAKERS | EDWARDS, PHILIP CHARLES | 3792 | §103 | Final Rejection | — | Pending | Dec 21, 2023 |
| 18571407 | AUGMENTED MEMORY COMPUTING: A NEW PATHWAY FOR EFFICIENT AI COMPUTATIONS | CHO, SUNG IL | 2825 | §103 | Final Rejection | 50d overdue | Pending | Dec 18, 2023 |
| 18525506 | CHIMERIC ANTIGEN RECEPTORS TARGETING CANCER | NGUYEN, QUANG | 1631 | §102§103§112 | Non-Final OA | — | Pending | Nov 30, 2023 |
| 18561889 | CHIMERIC ANTIGEN RECEPTOR-MODIFIED GRANULOCYTE-MACROPHAGE PROGENITORS FOR CANCER IMMUNOTHERAPY | WESTON, ALYSSA G | 1633 | §102§103§112Other | Non-Final OA | — | Pending | Nov 17, 2023 |
| 18561253 | PRODUCTION PROCESSES FOR HIGHLY VIABLE, ENGRAFTABLE HUMAN CHONDROCYTES FROM STEM CELLS | POPA, ILEANA | 1633 | §101§102§103 | Non-Final OA | — | Pending | Nov 15, 2023 |
| 18558275 | SYSTEMS AND METHODS FOR IDENTIFYING NOVEL PORE-FORMING TOXINS | TOMASZEWSKI, MICHAEL | 3681 | §101 | Non-Final OA | — | Pending | Oct 31, 2023 |
| 18385174 | CD70-TARGETED MICELLES ENHANCE HIF2a siRNA DELIVERY AND INHIBIT ONCOGENIC FUNCTIONS IN PATIENT-DERIVED CLEAR CELL RENAL CARCINOMA CELLS | KONOPKA, CATHERINE ANNE | 1635 | §102§103§112 | Non-Final OA | — | Pending | Oct 30, 2023 |
| 18380447 | CONVERSION OF WASTE PLASTICS TO HIGH-VALUE METABOLITES | HAUK TEODORO, PRICILA NMN | 1645 | §102§103 | Non-Final OA | — | Pending | Oct 16, 2023 |
| 18554917 | PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES | ALAWADI, SARAH | 1619 | §102§103Other | Final Rejection | 70d | Pending | Oct 11, 2023 |
| 18376040 | MIXED-KERNEL HETEROJUNCTION TRANSISTORS, FABRICATING METHODS, AND APPLICATIONS OF THE SAME | KIM, SU C | 2899 | §102 | Non-Final OA | — | Pending | Oct 03, 2023 |
| 18285227 | COMPOSITIONS AND METHODS FOR MODULTING INFLAMMATORY AND DEGENERATIVE DISORDER | LEE, JIA-HAI | 1658 | §101§102§103DP | Non-Final OA | — | Pending | Sep 29, 2023 |
| 18546472 | CELL-FREE DNA METHYLATION TEST | JONES, CHRISTINE MICHELLE | 1682 | §101§102§103§112 | Non-Final OA | — | Pending | Aug 15, 2023 |
| 18449154 | HIGHLY SENSITIVE AND SPECIFIC LUCIFERASE BASED REPORTER ASSAY FOR ANTIGEN DETECTION | HAQ, SHAFIQUL | 1678 | §103 | Non-Final OA | — | Pending | Aug 14, 2023 |
| 18263582 | ENZYME INHIBITORS AND VIRAL INFECTION THERAPY | VAJDA, KRISTIN ANN | 1622 | §102§112 | Non-Final OA | — | Pending | Jul 31, 2023 |
| 18273181 | Use Of Naturally Occurring Cyclic Peptides For Treatment Of SARS-COV-2 Infection | BOWLES, DAVID PAUL | 1654 | §102§103§112 | Final Rejection | 4d overdue | Pending | Jul 19, 2023 |
| 18212642 | ENGINEERED BOND LAYER FOR METALLIZATION OF POLYMER AND COMPOSITE SUBSTRATES | DILLON, DANIEL P | 1783 | §103 | Non-Final OA | — | Pending | Jun 21, 2023 |
| 18212068 | ENGINEERED CYCLOTIDES WITH POTENT BROAD ANTIMICROBIAL ACTIVITY | BANERJEE, KOYELI | 1658 | §103 | Final Rejection | — | Pending | Jun 20, 2023 |
| 18210978 | FLUID CHANNEL STRUCTURE OF NON-INVASIVE PROSTHETIC DEVICE | VIRK, ADIL PARTAP S | 3798 | §103§112 | Final Rejection | — | Pending | Jun 16, 2023 |
| 18184497 | ORGANIC PHOTOSENSITIVE DEVICES WITH EXCITON-BLOCKING CHARGE CARRIER FILTERS | CHERN, CHRISTINA | 1722 | §101 | Non-Final OA | 85d overdue | AI Ready | Mar 15, 2023 |
| 18097703 | POINT CLOUD CODING DEVICE, POINT CLOUD DECODING DEVICE, POINT CLOUD CODING METHOD, POINT CLOUD DECODING METHOD, AND PROGRAM | CHOI, TIMOTHY WING HO | 2671 | §103 | Final Rejection | — | Pending | Jan 17, 2023 |
| 18079714 | Endoscope with Pressure Recorder | STARKEY, OLIVIA GRACE | 3795 | §103§112 | Non-Final OA | — | Pending | Dec 12, 2022 |
| 17928690 | METHODS AND COMPOSITIONS FOR IN VITRO AFFINITY MATURATION OF MONOCLONAL ANTIBODIES | BUNKER, AMY M | 1684 | §103 | Final Rejection | 63d | Pending | Nov 30, 2022 |
| 17927454 | SCALABLE TRIO GUIDE RNA APPROACH FOR INTEGRATION OF LARGE DONOR DNA | SHEN, WU CHENG WINSTON | 1682 | §101§102§103§112 | Final Rejection | — | Pending | Nov 23, 2022 |
| 17948904 | Compositions and Methods for Treating Multidrug Resistant Bacterial Infection | KATAKAM, SUDHAKAR | 1658 | §103§112Other | Non-Final OA | — | Pending | Sep 20, 2022 |
| 17912313 | SCREENING METHODS TO IDENTIFY SMALL MOLECULE COMPOUNDS THAT PROMOTE OR INHIBIT THE GROWTH OF CIRCULATING TUMOR CELLS, AND USES THEREOF | SCHLIENTZ, LEAH H | 1618 | §103 | Final Rejection | — | Pending | Sep 16, 2022 |
| 17794920 | COMPOSITIONS AND METHODS TO TREAT NEUROLOGICAL DISEASES | GIBBS, TERRA C | 1635 | §103§112 | Non-Final OA | 72d | Pending | Jul 22, 2022 |
| 17786481 | UTILIZATION OF A FASTING-MIMICKING DIET TO REDUCE SENESCENT CELLS AND INFLAMMATION | O'HERN, BRENT T | 1793 | §112 | Final Rejection | 44d overdue | Pending | Jun 16, 2022 |
| 17642524 | ANALYSIS METHODS FOR MULTIPLEX TISSUE IMAGING INCLUDING IMAGING MASS CYTOMETRY DATA | WHALEY, PABLO S | 3619 | §101§103§112 | Non-Final OA | — | Pending | Mar 11, 2022 |
| 17618240 | ENGINEERED OFF-THE-SHELF IMMUNE CELLS AND METHODS OF USE THEREOF | ALSOMAIRY, SARAH ABDOALATIF | 1646 | §102 | Final Rejection | — | Pending | Dec 10, 2021 |
| 17541558 | FASTING MIMICKING KETOGENIC DIET (FMD) TO PROMOTE SKELETAL MUSCLE REGENERATION AND STRENGTH | MOSS, NATALIE M | 1653 | §103 | Final Rejection | 59d overdue | Pending | Dec 03, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUniversity of Southern California has 51 pending office actions as of October 2026, spread across 38 art units and 51 examiners.
Mark Donald Remaly has the most, with 1 of University of Southern California's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
